Psoriasis is a chronic dermatologic disease affecting 2% of the general population. Tumour necrosis factor (TNF)‐like weak inducer of apoptosis (TWEAK) is a newly defined member of the TNF family.… Click to show full abstract
Psoriasis is a chronic dermatologic disease affecting 2% of the general population. Tumour necrosis factor (TNF)‐like weak inducer of apoptosis (TWEAK) is a newly defined member of the TNF family. Increased serum levels of TWEAK were reported in inflammatory diseases. The relationship between serum TWEAK levels and severity of psoriasis has not yet been proven. Our aim was to clarify the change in serum TWEAK levels in response to conventional and anti‐TNF treatments.
               
Click one of the above tabs to view related content.